Arkadios Wealth Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-156	Closed	-$14K	–	1322
2021 Q3	$14K	Sell	156 -59	-27%	-$5.3K	﹤0.01%	1348
2021 Q2	$20K	Sell	215 -22	-9%	-$2.05K	﹤0.01%	1293
2021 Q1	$23K	Buy	237 +128	+117%	+$12.4K	﹤0.01%	937
2020 Q4	$10K	Buy	+109	New	+$10K	﹤0.01%	961